Stock listing

CRNX Stock Price, News, Filings & Events — Crinetics Pharmaceuticals, Inc.

Selected listing: CRNX · BX · CHF · CH

CRNX:BX is the listing for Crinetics Pharmaceuticals, Inc. in Switzerland. The company specializes in developing innovative therapies for endocrine diseases and related conditions, aiming to meet significant unmet medical needs. With a strong market capitalization of approximately $8.88 billion, Crinetics is actively advancing its pipeline of drug candidates. Recent news and filings highlight the company's ongoing commitment to research and development in this specialized area.

CRNX:BXCHFCHUpdated July 24, 2026
Crinetics Pharmaceuticals, Inc. logo
Ticker
CRNX:BX
Asset type
Stock
Market cap
$8.87B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BX
Currency
CHF

Crinetics Pharmaceuticals, Inc. CRNX:BX stock context

CRNX:BX is the listing for Crinetics Pharmaceuticals, Inc. in Switzerland. The company specializes in developing innovative therapies for endocrine diseases and related conditions, aiming to meet significant unmet medical needs. With a strong market capitalization of approximately $8.88 billion, Crinetics is actively advancing its pipeline of drug candidates. Recent news and filings highlight the company's ongoing commitment to research and development in this specialized area.

Research Crinetics Pharmaceuticals, Inc.

Alternate listings